Home›Compare›Emerge Weight Loss vs RxSpan MD

Emerge Weight Loss vs RxSpan MD: Which Is Better?

Head-to-head comparison of Emerge Weight Loss and RxSpan MD based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Emerge Weight Loss scores higher overall in our independent evaluation (68.6/100 vs 59.1/100), leading on trust & safety, value, experience, reputation. RxSpan MD comes out ahead on product range. RxSpan MD has the lower entry price (from $30/mo vs $224/mo), so the better value depends on which treatment you need.

Emerge Weight Loss is a small, Miami-area telehealth brand offering a single flat-rate, tirzepatide-only compounded GLP-1 program with named compounding-pharmacy partners.

Visit Emerge Weight Loss
59

RxSpan MD is a Beverly Hills telehealth practice founded by a plastic surgeon, offering compounded and branded GLP-1s, longevity peptides, hair-loss and ED treatment.

Visit RxSpan MD

Score Breakdown

DimensionEmerge Weight LossRxSpan MD
Overall Score68.6/100 ✓59.1/100
Trust & Safety30%74/100 ✓60/100
Value25%76/100 ✓58/100
Experience20%78/100 ✓52/100
Product Range15%42/10078/100 ✓
Reputation10%55/100 ✓45/100

At a Glance

Founded—2026
HeadquartersMiami, FLBeverly Hills, CA
Publicly tradedNoNo
Treatment categories14
Treatments listed19
Starting price$224/mo$30/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryEmerge Weight LossRxSpan MD
Weight Loss / GLP-1$224
Compounded Tirzepatide Auto-Pilot Plan
$249–$299
Compounded Semaglutide (injection or oral)

Emerge Weight Loss

+Names its compounding pharmacy partners (Hallandale and Empower Pharmacy), a transparency practice not all compounded-GLP-1 competitors follow
+Flat, all-in '$224/4 weeks, no hidden fees' pricing displayed publicly, with HSA/FSA accepted
+High Trustpilot rating (4.7/5) with specific praise for responsive, text-based support and reported weight-loss outcomes
−Tirzepatide-only — does not offer semaglutide, so patients who don't tolerate or prefer tirzepatide have no in-house alternative
−Small Trustpilot sample size (198 reviews) relative to competitors, so its rating is less statistically reliable
−Founding year and states served are not disclosed on the website, limiting how much operating history can be verified
Read the full Emerge Weight Loss review →

RxSpan MD

+Physician-founded practice with a named founder and a stated Beverly Hills address
+Offers both compounded (injection and oral) and branded GLP-1s, including cash-pay Zepbound listed at $500
+Third-party coverage reports named 503A pharmacy partners and free expedited shipping
−Compounded prices aren't visible on the public site; its product catalog failed to load during our research
−Brand-stated first-month prices ($249 semaglutide, $329 tirzepatide) are above peer averages, and renewal pricing is not published
−Site configuration shows an $80 initial visit fee that is not prominently disclosed
Read the full RxSpan MD review →

Emerge Weight Loss vs RxSpan MD — FAQ

Is Emerge Weight Loss better than RxSpan MD?

▾

Emerge Weight Loss scores higher overall in our independent evaluation (68.6/100 vs 59.1/100), leading on trust & safety, value, experience, reputation. RxSpan MD comes out ahead on product range. RxSpan MD has the lower entry price (from $30/mo vs $224/mo), so the better value depends on which treatment you need.

Is Emerge Weight Loss or RxSpan MD cheaper?

▾

RxSpan MD has the lower starting price (from $30/mo vs $224/mo for Emerge Weight Loss). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Emerge Weight Loss and RxSpan MD both offer?

▾

Both platforms treat Weight Loss / GLP-1. Emerge Weight Loss covers 1 treatment category total and RxSpan MD covers 4.

Still deciding?